Diferencia entre revisiones de «IV nitroglycerine alternatives»

 
(No se muestran 3 ediciones intermedias de 2 usuarios)
Línea 2: Línea 2:
*Suggestions for substitution during the IV shortage
*Suggestions for substitution during the IV shortage


===Nitroglycerine Bioavailability===
===[[Nitroglycerine]] Bioavailability===
*Oral <ref name="availability">http://sepia.unil.ch/pharmacology/index.php?id=51</ref>:    <1%
*Oral <ref name="availability">http://sepia.unil.ch/pharmacology/index.php?id=51</ref>:    <1%
*Sublingual <ref name="availability"/>: 38% (15-40%)
*Sublingual <ref name="availability"/>: 38% (15-40%)
Línea 16: Línea 16:
***IV [[enalapril]] 0.625-1.25mg IV bolus
***IV [[enalapril]] 0.625-1.25mg IV bolus
***IV [[hydralazine]] 5-10mg IV bolus
***IV [[hydralazine]] 5-10mg IV bolus
***IV [[nitropursside]]
***IV [[nitroprusside]]


==See Also==
==See Also==
Línea 25: Línea 25:
<references>
<references>


[[Category:Drugs]]
[[Category:Pharmacology]]
[[Category:Cardiology]]

Revisión actual - 20:51 22 sep 2019

Background

  • Suggestions for substitution during the IV shortage

Nitroglycerine Bioavailability

  • Oral [1]: <1%
  • Sublingual [1]: 38% (15-40%)
  • Topical [1]: 72%

Half-life[2]: 0.05 h

Suggested Substitutions[3]

See Also

References

<references>